[Impetigo].
Mazereeuw-Hautier
J
J
Service de Dermatologie, Hôpital Rangueil, 1, avenue Jean Poulhès, TSA 50032, 31059 Toulouse Cedex 09. mazereeuw-hautier@chu-toulouse.fr
D000284:Administration, Oral; D000328:Adult; D000658:Amoxicillin / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000627:therapeutic use; D017963:Azithromycin / Q000008:administration & dosage / Q000627:therapeutic use; D002511:Cephalosporins / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D019818:Clavulanic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005260:Female; D005672:Fusidic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007169:Impetigo / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy; D007223:Infant; D008297:Male; D008712:Methicillin / Q000008:administration & dosage / Q000627:therapeutic use; D016712:Mupirocin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D009824:Ointments; D010406:Penicillins / Q000008:administration & dosage / Q000627:therapeutic use; D011247:Pregnancy; D025762:Pristinamycin / Q000008:administration & dosage / Q000627:therapeutic use; D013411:Sulfadiazine / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000891:Anti-Infective Agents, Local; D002511:Cephalosporins; D009824:Ointments; D010406:Penicillins; D025762:Pristinamycin; D013411:Sulfadiazine; D019818:Clavulanic Acid; D005672:Fusidic Acid; D000658:Amoxicillin; D017963:Azithromycin; D016712:Mupirocin; D008712:Methicillin